Related references
Note: Only part of the references are listed.Leptomeningeal metastases: a RANO proposal for response criteria
Marc Chamberlain et al.
NEURO-ONCOLOGY (2017)
EpCAM-based flow cytometry in cerebrospinal fluid greatly improves diagnostic accuracy of leptomeningeal metastases from epithelial tumors
Bojana Milojkovic Kerklaan et al.
NEURO-ONCOLOGY (2016)
Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancer
Jin Sun Lee et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Circulating tumor cell levels are elevated in colorectal cancer patients with high tumor burden in the liver
Jussuf T. Kaifi et al.
CANCER BIOLOGY & THERAPY (2015)
Diagnostic and prognostic significance of flow cytometry immunophenotyping in patients with leptomeningeal carcinomatosis
D. Subira et al.
CLINICAL & EXPERIMENTAL METASTASIS (2015)
CellSearch® technology applied to the detection and quantification of tumor cells in CSF of patients with lung cancer leptomeningeal metastasis
Qian Tu et al.
LUNG CANCER (2015)
Prolonged Survival of Patients With Non-Small-Cell Lung Cancer With Leptomeningeal Carcinomatosis in the Modern Treatment Era
Jonathan W. Riess et al.
CLINICAL LUNG CANCER (2014)
The concentration of CYFRA 21-1, NSE and CEA in cerebro-spinal fluid can be useful indicators for diagnosis of meningeal carcinomatosis of lung cancer
Peng Wang et al.
CANCER BIOMARKERS (2013)
Molecular Profiling of Tumor Cells in Cerebrospinal Fluid and Matched Primary Tumors from Metastatic Breast Cancer Patients with Leptomeningeal Carcinomatosis
Mark Jesus M. Magbanua et al.
CANCER RESEARCH (2013)
Rare cell capture technology for the diagnosis of leptomeningeal metastasis in solid tumors
Lakshmi Nayak et al.
NEUROLOGY (2013)
Use of magnetic resonance imaging to detect neoplastic meningitis: Limited use in leukemia and lymphoma but convincing results in solid tumors
Sandra Pauls et al.
EUROPEAN JOURNAL OF RADIOLOGY (2012)
Circulating Tumor Cell Count Is a Prognostic Factor in Metastatic Colorectal Cancer Patients Receiving First-Line Chemotherapy Plus Bevacizumab: A Spanish Cooperative Group for the Treatment of Digestive Tumors Study
Javier Sastre et al.
ONCOLOGIST (2012)
Development of a new method for identification and quantification in cerebrospinal fluid of malignant cells from breast carcinoma leptomeningeal metastasis
Emilie Le Rhun et al.
BMC CLINICAL PATHOLOGY (2012)
Identification and enumeration of circulating tumor cells in the cerebrospinal fluid of breast cancer patients with central nervous system metastases
Akshal S. Patel et al.
ONCOTARGET (2011)
Prognostic factors and treatment options in patients with leptomeningeal metastases of different primary tumors: a retrospective analysis
Karin Oechsle et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Leptomeningeal metastases in the MRI era
J. L. Clarke et al.
NEUROLOGY (2010)
Circulating Tumor Cells: A Useful Predictor of Treatment Efficacy in Metastatic Breast Cancer
Minetta C. Liu et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data
Howard I. Scher et al.
LANCET ONCOLOGY (2009)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Frequent EpCam protein expression in human carcinomas
PT Went et al.
HUMAN PATHOLOGY (2004)
Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases
WJ Allard et al.
CLINICAL CANCER RESEARCH (2004)
Vascular endothelial growth factor in CSF - A biological marker for carcinomatous meningitis
G Stockhammer et al.
NEUROLOGY (2000)
Share Paper
